Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio (2021 - 2025)

Kiniksa Pharmaceuticals International (KNSA) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.92 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 23.2% year-over-year to 0.92, compared with a TTM value of 0.92 through Dec 2025, up 23.2%, and an annual FY2025 reading of 1.01, up 31.83% over the prior year.
  • Asset Utilization Ratio was 0.92 for Q4 2025 at Kiniksa Pharmaceuticals International, up from 0.87 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.92 in Q4 2025 and bottomed at 0.02 in Q4 2022.
  • Average Asset Utilization Ratio over 5 years is 0.49, with a median of 0.54 recorded in 2023.
  • Peak annual rise in Asset Utilization Ratio hit 2362.26% in 2023, while the deepest fall reached 84.9% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.13 in 2021, then crashed by 82.88% to 0.02 in 2022, then surged by 2362.26% to 0.54 in 2023, then soared by 39.17% to 0.75 in 2024, then increased by 23.2% to 0.92 in 2025.
  • Business Quant data shows Asset Utilization Ratio for KNSA at 0.92 in Q4 2025, 0.87 in Q3 2025, and 0.84 in Q2 2025.